CYP19A1 and multiple sclerosis: If these results are translatable to humans and to chronic neurodegenerative diseases, the enhanced expression of aromatase in multiple sclerosis lesions and in the hippocampus, the frontal cortex, and the basal nucleus of AD patients could represent an endogenous mechanism to protect the nervous system.